Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05820126 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial

Study acronym: CoVeRTS-HM
StatusRecruiting
PhasePhase 2
Started2025-05-16
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 31, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-07-29
Not Yet Recruiting→Recruiting Study Identification, Study Status, Conditions, Study Design, Eligibility, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2024-06-05→2026-06-01
Completion date2024-12-31→2026-12-31
Start dateestimated 2023-09-05→confirmed 2025-05-16
Study sites0→1
Eligibility criteria+118 characters
[...] atology ward with hematologic malignancy or marrow aplasia, this may include patients undergoing chemotherapy, immunotherapy, or hematopoietic stem cell transplant or patients admitted for symptom management. Moderate thrombocytopenia, platelet concentration 10-100 x1 [...] mboembolic disease Transfusion of platelet concentrate for >greadegrade 2 bleeding in preceding 24 hours Order for multiple platele [...] nterventions that may affect CoVeRTS-HM treatment or outcome Unable or unwilling to provide informed consent
2023-07-30
Study Identification, Study Status, Eligibility v1
Start date2023-06-05→2023-09-05
Eligibility criteria-13 characters
[...] omboembolic disease Transfusion of platelet concentrate for suspected>greade or confirmed2 bleeding in preceding 24 hours Order for multiple platelet [...]
2023-04-14
Original filing
This is a pilot trial to discover the feasibility of recruiting 50 pts over the course of 12 months. The trial is testing the efficacy of using cold-stored vs. room temperature stored (current standard of care) platelets to treat bleeding in persons with hematological disorders and thrombocytopenia.
Trial Details
NCT Number NCT05820126
Lead Sponsor Ottawa Hospital Research Institute
Conditions Hematologic Malignancy
Enrollment 50 participants
Start Date 2025-05-16
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-31